Fig. 3: Methylated DNA marker intensity in plasma samples.
From: Plasma assay of methylated DNA markers detects recurrent metastatic breast cancer
Each column contains a patient plasma sample, and each row represents a candidate MDM, which are sorted top to bottom by their AUC performance in both Benign and NED versus MBC cases as listed in Table 2. Protein markers CA153, CEA, and CA125 are included for comparison on the same patients. Missing grade, stage, or subtype values are in white.
